Our current study further raises the question that whether the IL-15/NKG2D axis would contribute to bystander activation of CD8+ T cells in other human viral diseases, and whether IL-15 or NKG2D could be considered as a therapeutic target in the treatment of the immunopathology of viral diseases. Here, KLRK1 is linked to viral infectious disease.